Cliff Asness's INSP Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 308,662 shares of Inspire Medical Systems, Inc. (INSP) worth $15.92 M, representing 0.01% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 28 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in INSP, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 281,622 shares. Largest reduction occurred in Q1 2025, reducing 196,641 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Inspire Medical Systems (INSP) Holding Value Over Time
Track share changes against reported price movement
Quarterly Inspire Medical Systems (INSP) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +281,622 | Add 1041.50% | 308,662 | $51.58 |
| Q4 2025 | -22,377 | Reduce 45.28% | 27,040 | $92.23 |
| Q3 2025 | -71,993 | Reduce 59.30% | 49,417 | $74.20 |
| Q2 2025 | -120,793 | Reduce 49.87% | 121,410 | $129.77 |
| Q1 2025 | -196,641 | Reduce 44.81% | 242,203 | $153.20 |
| Q4 2024 | -7,567 | Reduce 1.70% | 438,844 | $185.38 |
| Q3 2024 | +214,566 | Add 92.55% | 446,411 | $209.20 |
| Q2 2024 | +140,090 | Add 152.68% | 231,845 | $133.83 |
| Q1 2024 | +28,312 | Add 44.63% | 91,755 | $214.79 |
| Q4 2023 | +49,096 | Add 342.20% | 63,443 | $203.43 |
| Q3 2023 | +8,538 | Add 146.98% | 14,347 | $198.44 |
| Q2 2023 | -2,633 | Reduce 31.19% | 5,809 | $324.64 |
| Q1 2023 | +745 | Add 9.68% | 8,442 | $234.07 |
| Q4 2022 | -3,825 | Reduce 33.20% | 7,697 | $251.88 |
| Q3 2022 | +3,426 | Add 42.32% | 11,522 | $177.40 |
| Q2 2022 | -2,041 | Reduce 20.13% | 8,096 | $182.68 |
| Q1 2022 | -5,797 | Reduce 36.38% | 10,137 | $256.68 |
| Q4 2021 | +1,254 | Add 8.54% | 15,934 | $230.07 |
| Q3 2021 | +148 | Add 1.02% | 14,680 | $232.90 |
| Q2 2021 | +1,225 | Add 9.21% | 14,532 | $193.23 |
| Q1 2021 | +1,229 | Add 10.18% | 13,307 | $206.96 |
| Q4 2020 | +1,819 | Add 17.73% | 12,078 | $188.11 |
| Q3 2020 | +2,312 | Add 29.09% | 10,259 | $129.06 |
| Q2 2020 | -1,087 | Reduce 12.03% | 7,947 | $87.08 |
| Q1 2020 | +104 | Add 1.16% | 9,034 | $60.33 |
| Q4 2019 | -10 | Reduce 0.11% | 8,930 | $74.24 |
| Q3 2019 | -49,382 | Reduce 84.67% | 8,940 | $61.07 |
| Q2 2019 | +58,322 | New Buy | 58,322 | $60.65 |
Cliff Asness's Inspire Medical Systems Investment FAQs
Cliff Asness first purchased Inspire Medical Systems, Inc. (INSP) in Q2 2019, acquiring 58,322 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Inspire Medical Systems, Inc. (INSP) for 28 quarters since Q2 2019.
Cliff Asness's largest addition to Inspire Medical Systems, Inc. (INSP) was in Q1 2026, adding 308,662 shares worth $15.92 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 308,662 shares of Inspire Medical Systems, Inc. (INSP), valued at approximately $15.92 M.
As of the Q1 2026 filing, Inspire Medical Systems, Inc. (INSP) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Inspire Medical Systems, Inc. (INSP) was 446,411 shares, as reported at the end of Q3 2024.